INIFY — INIFY Laboratories AB Share News
0.000.00%
- NOK849.05m
- NOK830.63m
- SEK22.01m
Brief: Inify Laboratories Gets CQC Registration, Is Fully Operational In UK
Brief: Inify Laboratories Q1 Sales Up At SEK 6.3 Mln
Brief: Inify Laboratories Signs Agreement With Region Jämtland Härjedalen
Brief: Inify Laboratories Has Signed An Agreement With Region Jamtland Harjedalen For Prostate Cancer Diagnostics
Brief: Inify Laboratories Q4 EBITDA Loss At SEK 19.9 Mln
Brief: Inify Laboratories Announces Results Of Private Placement
Brief: Inify Laboratories Gets Subscriptions For 25,759,315 Private Placement Shares, At Offer Price
Brief: Inify Laboratories Announces Application Periods For Fully Guaranteed Private Placement, Fully Guaranteed Repair Issue
Brief: Inify Laboratories: Updated Timetable For Private Placement, Repair Issue Settlement
Brief: Inify Laboratories Proposes NOK 100 Mln Share Issue
Brief: Inify Laboratories Sales In Q2 Amounted To Sek 5.6 Million
Brief: Inify Laboratories Sales In Q1 Amounted To SEK 5.1 Mln
Brief: Inify Laboratories Q4 EBITDA Loss SEK 13,1 Mln
Brief: Inify Laboratories To Issue New Shares In Private Placement And Subsequent Offering
Brief: Inify Laboratories Enter Into Agreement With Swedish Region
Brief: Inify Laboratories: Successful Placement Of Fully Guaranteed Private Placement
Brief: Inify Laboratories Launches Private Placement Of 30 Mln New Shares
Brief: Inify Proposes Equity Issue With Proceeds Of SEK 150 Mln
Brief: Inify Laboratories To Establish Operations In UK